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Research
Epidemiologic studies suggest that individu-
als with diabetes may be susceptible to the 
deleterious effects of exposure to PM2.5 (par-
ticulate matter with aerodynamic diameter 
≤ 2.5 µm)  (Goldberg et al. 2006; O’Neill 
et al. 2007; Zanobetti and Schwartz 2001, 
2002). We recently found, in a panel study 
on adult individuals with diabetes, significant 
associations between altered endothelial cell 
function and PM2.5 exposure with a lag of 
1–3 days (Schneider et al. 2008). Moreover, 
we observed that this effect was greatest 
among participants who had a high body mass 
index (BMI); who had high levels of glyco-
sylated hemoglobin A1c (HbA1c), a marker 
associated with poor insulin resistance; or who 
had the null polymorphism for the antioxi-
dant enzyme glutathione S-transferase M1 
(GSTM1). These latter observations suggest 
that more severe insulin resistance and oxida-
tive stress may be underlying features con-
tributing to diabetic individuals’ susceptibility 
to PM2.5-associated health effects. We also 
observed associations between increased blood 
levels of interleukin-6 (IL-6) and tumor necro-
sis factor-α (TNFα) with ambient PM levels 
with a lag of 2 days, and changes in indicators 
of cardiac repolarization both immediately 
and with 4-day lags (Schneider et al. 2010).
Recent evidence from controlled inha-
lation challenge studies in both healthy and 
susceptible individuals has shown that expo-
sure to air pollutants has the ability to mod-
ify cell-surface markers involved in activation 
of the innate immune response to defend 
the host from infection (Alexis et al. 2008, 
2010). Exposure to PM as well as ozone can 
up-regulate the expression of airway immune 
cell-surface pheno  types such as the major 
histo  compatibility complex class II mole-
cule HLA-DR and costimulatory molecules 
CD80 and CD86 [for a full definition, see 
Supplemental Material, Table 1 (doi:10.1289/
ehp.1002543)], all receptors that mediate and 
promote antigen presentation (Alexis et al. 
2005, 2010; Lay et al. 2007). Moreover, this 
effect is not restricted to mucosal surfaces of 
the airways. Circulating inflammatory cells 
also have modified surface phenotypes after 
inhalation challenge with airborne irritants. 
Frampton et al. (2006) have reported modified 
CD11b [see Supplemental Material, Table 1 
(doi:10.1289/ehp.1002543)] expression on 
blood monocytes and eosinophils in asthmatics 
exposed for 2 hr to 10 µg/m3 of ultrafine par-
ticulate matter (PM). Moreover, we recently 
reported a link between the inverse association 
of PM2.5 exposure and lung function with cell-
surface marker expression on circulating neu-
trophils in asthmatic children (Svendsen et al. 
2007). In that study, muted baseline expres-
sion of mCD14 [see Supplemental Material, 
Table 1 (doi:10.1289/ehp.1002543)] was asso-
ciated with significantly reduced pulmonary 
function (forced expiratory volume in 1 sec; 
FEV1) with each interquartile-range increase in 
PM2.5 concentration. These results suggest that 
asthmatic children with altered innate immune 
responses may have decreased capacity to 
respond to bacterial components on inhaled 
PM, potentially predisposing them to greater 
opportunistic infection.
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Ba c k g r o u n d: Exposure of humans to air pollutants such as ozone and particulate matter (PM) 
may result in airway and systemic inflammation and altered immune function. One putative mecha-
nism may be through modification of cell-surface costimulatory molecules.
oBjectives: We examined whether changes in expression of costimulatory molecules on circulating 
cells are associated with ambient levels of fine PM [aerodynamic diameter ≤ 2.5 μm (PM2.5)] in a 
susceptible population of diabetic individuals.
Me t h o d s : Twenty subjects were studied for 4 consecutive days. Daily measurements of PM2.5 and 
meteorologic data were acquired on the rooftop of the exam site. Circulating cell-surface markers that 
mediate innate immune and inflammatory responses were assessed by flow cytometry on each day. 
Sensitivity analysis was conducted on glutathione S-transferase M1 (GSTM1) genotype, body mass 
index, and glycosylated hemoglobin A1c (HbA1c) levels to determine their role as effect modifiers. 
Data were analyzed using random effects models adjusting for season, weekday, and meteorology.
re s u l t s: We found significantly increased monocyte expression (mean fluorescent intensity) of 
CD80, CD40, CD86, HLA-DR, and CD23 per 10-μg/m3 increase in PM2.5 at 2- to 4-day lag 
times after exposure. These findings were significantly higher in obese individuals, in individuals 
with HbA1c > 7%, and in participants who were GSTM1 null.
co n c l u s i o n s: Exposure to PM2.5 can enhance antigen-presenting cell phenotypes on circulating 
cells, which may have consequences in the development of allergic or autoimmune diseases. These 
effects are amplified in diabetic individuals with characteristics that are associated with insulin resis-
tance or with oxidative stress.
key w o r d s : air pollution, costimulatory receptors, diabetes, inflammation, flow cytometry, par-
ticulate matter. Environ Health Perspect 119:778–783 (2011).  doi:10.1289/ehp.1002543 [Online 
17 December 2010]PM2.5 modifies monocyte receptors in diabetes
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Unlike for asthmatics, it is currently 
unknown whether diabetic individuals have 
impaired innate immune surface phenotypes on 
circulating cells as a result of exposure to PM2.5. 
Therefore, we examined the effects of ambient 
PM2.5 exposure on circulating cell-surface phe-
notypes in adults with type 2 diabetes. We fur-
ther analyzed potential modifiers of this response 
related to markers of insulin resistance (BMI and 
HbA1c) as well as a gene related to oxidative 
stress (GSTM1), which we showed earlier was 
associated with enhanced endothelial cell dys-
function and increased vascular inflammation 
in this study population (Schneider et al. 2008, 
2010). We hypothe  sized that there would be an 
association between changes in ambient PM2.5 
levels and modified expression of circulating cell-
surface phenotypes that mediate innate immune 
activity, and that this effect would be more pro-
nounced in individuals who were obese, had 
elevated HbA1c, or were GSTM1 null.
Materials and Methods
Study population. Twenty volunteers 48–72 
years of age with type 2 diabetes participated 
in the study. Inclusion and exclusion criteria 
were identical to our recent report and are 
presented in detail in that report (Schneider 
et al. 2008).
Each  participant  visited  the  U.S. 
Environmental Protection Agency’s (EPA) 
National Health Effects Environmental 
Laboratory, Environmental Public Health 
Division (EPHD), in Chapel Hill, North 
Carolina (USA), on 5 consecutive weekdays 
between November 2004 and December 2005. 
All volunteers signed a written consent form, 
and the study protocol was approved by the 
University of North Carolina Human Studies 
Biomedical Institutional Review Board as well 
as by the U.S. EPA.
Clinical procedures. On Monday morn-
ing of each examination week, the partici-
pants completed a baseline questionnaire on 
individual characteristics, health status, pul-
monary and cardiac symptoms, medication, 
and smoking history. In each of the next four 
mornings, participants checked into the medi-
cal station in a fasting state and without hav-
ing taken their antidiabetic medication. Upon 
arriving at the medical station each morning, 
fasting glucose concentration was measured 
with a point-of-care glucose meter.
Venipuncture and assays. Each morning, 
approximately 60 mL peripheral venous blood 
was taken from an antecubital site. Both serum 
and plasma were obtained, stored at –80°C, 
and used to measure markers of acute phase 
response and vascular inflammation (Schneider 
et al. 2010). HbA1c was measured with Roche 
Tina Quant by LabCorp. (Burlington, NC, 
USA) on the day the blood was drawn and 
was analyzed only from the first blood sample. 
Study participants were also genotyped for the 
presence or absence of the null polymorphism 
of GSTM1, a gene that belongs to the anti-
oxidant defense family, as described previously 
(Schneider et al. 2010).
Flow cytometry. Flow cytometry was per-
formed on a FACSORT instrument (Becton 
Dickinson, Franklin Lakes, NJ, USA) with 
approximately 1 mL fresh blood. Inflammatory 
cell populations (monocytes, neutrophils, 
eosinophils, and lymphocytes) in blood were 
identified and gated based on light scatter 
properties (forward scatter and side scatter). 
Whole blood was stained with saturating con-
centrations of monoclonal antibodies (10 µL) 
to cell-surface antigens (Beckman Coulter, 
Inc., Miami, FL, USA). After red cell lysis, 
inflammatory cells were resuspended in fixa-
tive (2.5% paraformaldehyde) and analyzed 
by flow cytometry within 24 hr using a panel 
of fluorescein- and   phycoerythrin-conjugated 
monoclonal antibodies (Figure 1). The mean 
fluorescence intensity (MFI) of the cells stained 
with isotypic control antibodies was sub-
tracted from the MFI of the cells stained with 
specific antibodies to get a measure of surface 
receptor–specific MFI. The percentage of cells 
that expressed a surface marker above con-
trol levels was also calculated. Surface marker 
expression was analyzed using the Cell Quest 
software (Becton Dickinson). For our analy-
sis we analyzed only monocyte and neutro-
phil populations. The panel of antibodies (with 
associated function) we used was CD23 [low-
affinity immunoglobulin (Ig) E receptor], Fcε 
receptor-1 (FcεR1; high-affinity IgE recep-
tor), CD80, CD86, CD40, HLA-DR (a major 
histocompatibility complex class II; antigen 
presentation), CD1a (antigen presentation), 
CD11b/CR3, CD54/intercellular adhesion 
molecule-1 (ICAM-1; complement-mediated 
phagocytosis, cell migration; immune complex 
binding), CD14, CD16, and CD64 (lipopoly-
saccharide; inflammation; innate immunity). 
For neutrophils (percentage and MFI) we 
analyzed only CD11b/CR3, CD14, CD16, 
and CD64 [for full definition of cell-surface 
markers, see Supplemental Material, Table 1 
(doi:10.1289/ehp.1002543)].
Air pollution monitoring. Concentrations of 
PM2.5 (average from 0900 hours to 0900 hours 
next day) were measured on each clinic day and 
for the 4 prior days with a 3000K Versatile Air 
Pollution Sampler (URG Corp., Chapel Hill, 
NC, USA) (Williams et al. 2000) located on 
the EPHD rooftop approximately 30 m above 
ground level. In addition, daily 24-hr concen-
trations (midnight to midnight) of fine ambient 
PM2.5 mass were obtained from a monitoring 
station located approximately 44 km (27 miles) 
east of the EPHD building and operated by the 
State of North Carolina. The Spearman cor-
relation between both PM2.5 measurements was 
0.85 across the 14-month study period, and 
the network data were used to impute missing 
rooftop data based on a linear regression model. 
Of 13 missing daily averages relevant for the 
health outcome analysis, 11 could be imputed 
and only two remained missing.
Figure 1. Procedure example. (A) Scatterplot of gated leukocyte populations based on forward (FSC) and side (SSC) light scatter properties: lymphocytes (red), 
monocytes (blue), neutrophils (green), and eosinophils (pink). (B and C) Quadrant plots showing monocytes in the control region using fluorescein isothiocyanate 
(FITC)– and phycoerythrin (PE)–labeled IgG1 as isotypic controls for CD80 versus CD40, respectively, showing > 80% CD40+ cells (C). 
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Continuous 2-min measurements of air 
temperature, barometric pressure, and rela-
tive humidity were obtained from the EPHD 
rooftop, and 24-hr averages were calculated.
Statistical analyses. The study was con-
ducted as a panel study with four repeated 
measurements per participant. Thus, every 
person acted as his or her own control, which 
limited the need for an adjustment for patient 
characteristics in the analysis.
Data were analyzed using the statistical 
package SAS (version 9.1; SAS Institute Inc., 
Cary, NC, USA). For the analysis of the PM 
effect, additive mixed models with a random 
participant effect and “compound symmetry” 
covariance structure were used (Fitzmaurice 
et al. 2004; Greven et al. 2006). Models to 
identify meteorologic and temporal deter-
minants as potential confounders were built 
for each outcome variable separately and are 
described in detail in our previous report 
(Schneider et al. 2008). The exposure, in this 
case rooftop PM2.5 mass, was considered as 
an immediate (lag 0) or a delayed (lag 1 to 
lag 4) effect over 5 days. Effect estimates are 
presented as percent changes of the mean out-
come variable together with 95% confidence 
intervals (CIs) for a 10-µg/m3 increment in 
fine ambient PM2.5 mass.
Sensitivity was analyzed by changing the 
covariance structure to first-order autocor-
relation for selected PM2.5 results. Moreover, 
to assess the heterogeneity across study par-
ticipants in this repeated measures study, we 
examined patient-specific, random slope mod-
els for selected PM2.5 results.
Effect modification was examined using 
dichotomous indicator variables that included 
BMI (cut-point, 30 kg/m2) and HbA1c (cut-
point, 7%; measured only once), both charac-
teristics associated with insulin resistance. 
In addition, gene–environment interaction 
was assessed for the null polymorphisms of 
GSTM1, a characteristic associated with sus-
ceptibility to oxidative stress.
Results
Subject demographics and clinical charac­
teristics. Table 1 lists study participant 
demographics. All participants were current 
nonsmokers, and their BMIs ranged from 20 
to 44 kg/m2; 40% (n = 8) were overweight 
(20–25 kg/m2), and 55% (n = 11) were obese 
(≥ 30 kg/m2). Forty percent of subjects had 
a systolic blood pressure > 140 mmHg, indi-
cating stage 1 hypertension; most participants 
had a history of hypertension and dyslipi-
demia. Duration of type 2 diabetes ranged 
from 2 months to 23 years [see Supplemental 
Material, Table 2 (doi:10.1289/ehp.1002543)]. 
Most were being treated with oral antihyper-
glycemic medications, and roughly half were 
taking statins and antihypertensives. About two-
thirds of the participants regularly took aspirin.
Air pollutant and meteorology measure­
ments. The 24-hr PM2.5 values over the study 
period were generally below the U.S. National 
Ambient Air Quality Standard (NAAQS) of 
35 µg/m3, and the mean over the study period 
was below the annual average NAAQS of 
15 µg/m3 [see Supplemental Material, Table 3 
(doi:10.1289/ehp.1002543)]. Within the rele-
vant 5 days of exposure (lag 0 to lag 4), three 
different individuals with a total of six observa-
tions experienced PM2.5 exposure > 35 µg/m3. 
The median of the within-individual PM2.5 
ranges was 7.9 µg/m3. Correlations between 
PM2.5 and meteorology parameters as well as 
the time course of PM2.5 and air temperature 
during the study period can be found in a pre-
vious publication (Schneider et al. 2008).
Description of immunologic outcomes. For 
a description of cell-surface marker function 
and mean values for the analyzed cytokines and 
cell-surface markers, see Supplemental Material, 
Tables 1 and 4, respectively (doi:10.1289/
ehp.1002543). The mean values represent the 
average of 20 individual means (percentage 
and MFI), where each individual mean was the 
average of measurements on 4 consecutive days.
Association of PM2.5 with cell­surface 
marker expression. Figures 2 and 3 show 
results of the analysis of surface marker acti-
vation on monocytes; activation is expressed 
as the percent change in mean expression 
(based on MFI or the percentage of cells 
that expressed a surface marker) per 10-µg/
m3 increase in PM2.5. We report significant 
increments of surface markers that medi-
ate antigen presentation, that is, CD40 and 
CD80 at lags 2 and 3, and CD86, HLA-DR, 
and IgE processing, that is, CD23, at lag 4. 
An increase in CD1a (antigen presentation) 
tended toward significance at lag 0. Expression 
Table 1. Study population characteristics: current 
nonsmoking subjects with type 2 diabetes mellitus 
(n = 20).
Characteristic
Mean or 
total n
Mean age (years)  60
Male sex (n)  12
Ethnicity (n)
Caucasian 13
African American 6
Hispanic American 1
BMI (kg/m2)
Mean 33
≥ 30 kg/m2 (n) 11
Mean systolic blood pressure ≥ 140 mmHg (n) 8
HbA1c ≥ 7%a (n) 9b
Smoking (n)
Never-smoker 11
Ex-smoker 9
Null polymorphism of GSTM1 (n) 9c
aHbA1c was measured once at the baseline visit. bData 
were missing from two subjects.cThree subjects declined 
permission for genetic testing.
Figure 2. Effect estimates based on percentages of peripheral blood monocyte cellular activation markers 
(with 95% CIs) for immediate (lag 0) and delayed (lags 1–4) associations with PM2.5: IgE group (A), APC 
group parts 1 (B) and 2 (C), and cell migration group (D). Abbreviations: aff, affinity; rec, receptor.
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of CD54/ICAM-1, a marker of leukocyte 
migration, and CD11b, a receptor that medi-
ates complement-regulated phagocytosis, had 
a significant decrease associated with an incre-
ment in PM2.5 at lag 2 and 3 (CD54 only) 
based on the percentage of   positive cells.
Figures 4 and 5 show results of the analysis 
of surface marker activation on neutrophils. 
We observed a significant decrease in expres-
sion of CD14 (endotoxin receptor) and CD16 
(receptor for IgG-mediated immune responses) 
based on MFI at lags 2 and 3, respectively, per 
increment in PM2.5. We found no statistically 
significant association with PM2.5 for CD14, 
CD16, CD64, or FcεR1 on monocytes or 
CD11b on neutrophils at any time point. For 
absolute changes of all analyzed cell-surface 
markers based on an increment of 1 µg/m3 
in PM2.5, see Supplemental Material, Table 5 
(doi:10.1289/ehp.1002543).
Effect modification on cell­surface markers. 
For the monocyte markers CD40 and CD80, 
we found strong effect modification by BMI, 
HbA1c level, and GSTM1-null polymorphism 
based on MFI. Both markers showed far 
stronger associations with PM2.5 at lags 0, 2, 
and 3 in obese individuals, in individuals with 
elevated HbA1c, and in GSTM1-null indi-
viduals. The effect size in the more susceptible 
subgroups was comparable for both markers at 
lag 0, although not significant for CD80, but 
was much higher for CD80 than for CD40 at 
lags 2 and 3 (Figures 6 and 7).
Sensitivity analyses on cell­surface mark­
ers. The estimated effects were not sensitive 
to changing the covariance matrix from com-
pound symmetry to first-order autocorrela-
tion. Random slopes showed consistent PM2.5 
associations for almost all study participants 
for monocyte markers CD40 and CD80, 
based on MFI [see Supplemental Material, 
Figures 1 and 2 (doi:10.1289/ehp.1002543)]. 
However, for CD23 the effect at lag 4 was 
driven mainly by two individuals [participants 
4 and 10: One was obese, both had a high 
level of HbA1c, and one was GSTM1 null; see 
Supplemental Material, Figure 3 (doi:10.1289/
ehp.1002543)]. Because the individual iden-
tification numbers order the participants in 
general across the study period, seasonal dif-
ferences would appear as a wave pattern in 
these subject-specific slopes. In the absence of 
such a pattern, which is the case in the present 
analysis, we believe that we can conclude the 
absence of major seasonal differences.
Discussion
Previous studies demonstrate that individu-
als with diabetes are susceptible to the del-
eterious effects of PM2.5 exposure (Goldberg 
et al. 2006; O’Neill et al. 2007; Zanobetti 
and Schwartz 2001, 2002). We recently 
reported that PM2.5 exposure was associated 
with endothelial cell dysfunction in patients 
with type 2 diabetes and that factors such 
as obesity and an elevated HbA1c level, as 
well as deficient antioxidant gene capabil-
ity (GSTM1 null), enhanced this deleterious 
association (Schneider et al. 2008). We also 
reported associations between PM2.5 exposure 
and changes in markers of vascular inflam-
mation and cardiac function (Schneider et al. 
2010). Here we report, for the same cohort 
of adult diabetic patients, that increases in 
PM2.5 exposure are associated with modified 
circulating cell-surface markers that mediate 
Figure 3. Effect estimates based on MFI for peripheral blood monocyte cellular activation markers (with 
95% CIs) for (lag 0) and delayed (lags 1–4) associations with PM2.5: IgE group (A), APC group parts 1 (B) 
and 2 (C), and cell migration group (D). Abbreviations: aff, affinity; rec, receptor.
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Figure 4. Effect estimates based on percentages of neutrophil cellular activation markers (with 95% CIs) 
for immediate (lag 0) and delayed (lags 1–4) associations with PM2.5.
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Figure 5. Effect estimates based on MFI for neutrophil cellular activation markers (with 95% CIs) for imme-
diate (lag 0) and delayed (lags 1–4) associations with PM2.5.
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innate immune responses 2–4 days after expo-
sure. Furthermore, and like our findings on 
endothelial cell dysfunction, this association 
was enhanced in obese participants, in individ-
uals with elevated HbA1c levels, and in indi-
viduals with the GSTM1-null polymorphism. 
The cell-surface receptors that were modified 
were up-regulated and reflected an enhanced 
antigen presentation phenotype, a finding 
we have reported previously in controlled 
exposure studies on healthy individuals for 
other pollutants, such as ozone and endotoxin 
(Alexis et al. 2005, 2008; Lay et al. 2007).
Relatively few studies have reported an 
association between exposure to ambient PM 
and altered innate immune activity on circulat-
ing cells in susceptible individuals. Here we 
report that adults with type 2 diabetes have 
significantly up-regulated surface expression of 
CD40 and CD80 with a lag of 2 and 3 days 
and significantly elevated CD86, HLA-DR, 
and CD23 expression at a lag of 4 days on 
circulating monocytes. Increased expression of 
these surface molecules may reflect a skewing 
toward an antigen presentation phenotype, 
including IgE-mediated antigen presentation, a 
pathway critical in allergic asthma pathogenesis 
(Kim et al. 2010). We also observed a signifi-
cant decrease in the proportion of monocytes 
that expressed CD54/ICAM-1, a cell-surface 
integrin involved in cell adherence and migra-
tion activity. Because several aspects of innate 
immunity are altered in patients with diabetes, 
namely, depressed polymorphonuclear leuko-
cyte function and altered leukocyte adherence, 
chemotaxis, and phagocytosis (Delamaire et al. 
1997; Gallacher et al. 1995; Valerius et al. 
1982), these data suggest that diabetic individ-
uals may be at further risk of innate immune 
dysfunction after exposure to PM2.5.
Among the potential consequences of 
monocytes demonstrating antigen-presenting 
cell (APC) characteristics such as up-regulated 
surface expression of CD40, CD80 and CD86, 
is the potential to activate naive T-helper 
cells. Although this alone may not induce a 
deleterious effect on adaptive immunity, it 
would likely cause a simultaneous decrease in 
the number of monocytes performing classic 
phagocyte functions, such as pathogen recogni-
tion, phagocytosis, and intracellular destruc-
tion of microbes. Indeed, our data showed 
a decrease in the proportion of monocytes 
expressing CD11b, the surface molecule asso-
ciated with pathogen recognition and com-
plement-mediated phagocytosis. Although 
significant, the absolute changes we observed 
in surface marker expression were relatively 
modest, so the interpretation of their direct 
impact on innate immunity remains cautious. 
The surface markers, however, may be useful as 
markers of risk and further examination.
Our data showed that certain effect modi-
fiers significantly influenced the relation-
ship between PM2.5 exposure and altered 
cell-surface phenotypes. These included ele-
vated HbA1c levels, the GSTM1-null poly-
morphism, and being obese. Oxidant stress 
or decreased antioxidant defense capability 
and the resultant increase in inflammation 
may be a common link between these effect 
modifiers and perhaps offer some mechanis-
tic insight into the effects of PM2.5 on type 2 
diabetes. For example, obesity can itself be 
considered a low-grade inflammatory condi-
tion (Eklund 2009). Endogenous factors inher-
ent in type 2 diabetes, such as oxidative stress, 
promote inflammation and will further affect 
the impact of PM2.5 exposure on diabetics. 
Evidence suggests that free radicals are formed 
disproportionately in diabetes by glucose oxi-
dation, nonenzymatic glycation of proteins, 
and the subsequent oxidative degradation 
of glycated proteins (Furukawa et al. 2004). 
Figure 6. CD40 monocyte effect modification estimates (with 95% CIs) based on MFI for immediate (lag 0) 
and delayed (lags 1–4) associations with PM2.5: BMI (A), HbA1c (B), and GSTM1 (C).
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Figure 7. CD80 monocyte effect modification estimates (with 95% CIs) based on MFI for (lag 0) and delayed 
(lags 1–4) associations with PM2.5: BMI (A), HbA1c (B), and GSTM1 (C). 
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Reactive oxygen species generation is both a 
consequence and a promoter of inflammation. 
Several studies have shown that inflammation 
can increase insulin resistance and result in 
increased levels of blood sugar. Costimulatory 
molecules, such as CD80/86 and CD40, have 
long been known to be important in regulat-
ing inflammatory responses in the adaptive 
immune response, and more recently in innate 
immunity as well. Therefore, the more pro-
nounced effects of PM2.5 on these cell-surface 
markers may reflect an enhanced underlying 
inflammation and a reduced ability to cope 
with PM-induced inflammation. GSTM1-null 
individuals have been shown to have more pro-
nounced inflammation in response to oxidant 
pollutants such as diesel, tobacco smoke, and 
ozone (Alexis et al. 2009; Gilliland et al. 2004, 
2006). In this cohort of subjects, we previously 
observed an association between elevated proin-
flammatory cytokines IL-6 and TNFα and cir-
culating eosinophils with increments in PM2.5 
exposure at lags similar to those reported here 
for cell-surface markers that mediate inflamma-
tion and IgE allergic responses, respectively [see 
Supplemental Material, Figure 4 (doi:10.1289/
ehp.1002543)] (Schneider et al. 2010). All 
Pearson correlations between the cell-surface 
markers and the two inflammatory markers 
were very low, except for two that were some-
what moderate: IL-6 and CD1a (monocytes, 
MFI), r = 0.56; IL-6 and CD80 (monocytes, 
MFI), r = 0.41 [see Supplemental Material, 
Tables 6–9 (doi:10.1289/ehp.1002543)]. 
Because dendritic cells express high levels of 
CD1a and CD80 and produce high levels of 
cytokines such as IL-6, it is possible that PM2.5-
induced skewing of cells toward an APC phe-
notype may in part explain these associations.
Limitations. In this study we used daily 
PM2.5 mass values from the rooftop of the 
U.S. EPA EPHD building. In addition, we 
obtained PM2.5 values from a state monitoring 
station 27 miles away from the EPHD build-
ing. We found a strong correlation between 
these two sets of measurements, suggesting that 
we were accurately assessing ambient exposure 
of the study participants. However, our study 
shows the general limitation of accurately mea-
suring exposure of participants, in common 
with all panel studies with a similar design. All 
the subjects lived within a 30-mile radius of 
Chapel Hill. Of course, there could be vari-
able exposure to traffic as the participants com-
muted to work and to the EPHD building, 
which is difficult to capture. Although ambient 
exposures are measured with some imprecision, 
these exposure measurement errors are non-
differential with respect to either true ambient 
exposure or the clinical measurements. As such, 
these Berkson measurement errors will tend to 
bias our results toward the null.
A small exposure gradient within the 
repeated measurements of each individual 
only limits the statistical power of the study 
to detect weak associations, but none would 
produce a substantial bias away from the null 
hypothesis.
As with any study that examines many 
different end points, multiple testing and as 
a consequence the potential for false-positive 
results can be a problem, especially with so 
many effect modifiers.
Conclusion
Similar to our previous finding in this cohort of 
individuals with type 2 diabetes where endothe-
lial dysfunction was associated with increases 
in PM2.5 exposure, we found that incremental 
increases in PM2.5 exposure are associated with 
up-regulated blood monocyte surface expres-
sion of costimulatory molecules that promote 
an APC phenotype. This effect was enhanced 
in diabetics who had elevated HbA1c levels, 
had the GSTM1-null phenotype, or were obese. 
These data suggest that oxidative stress as well 
as severe insulin resistance may be an underly-
ing feature contributing to the effects of PM2.5 
exposure on innate immune responses in indi-
viduals with type 2 diabetes.
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